Skip Navigation


European Heart Journal Advance Access originally published online on November 5, 2007
European Heart Journal 2007 28(23):2827-2829; doi:10.1093/eurheartj/ehm511
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/23/2827    most recent
ehm511v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hindricks, G.
Right arrow Articles by Kottkamp, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hindricks, G.
Right arrow Articles by Kottkamp, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2007. For permissions please email: journals.permissions@oxfordjournals.org

From MAZE to ICE: new concepts and new technologies for surgical ablation of atrial fibrillation

Gerhard Hindricks1,* and Hans Kottkamp2

1 University of Leipzig, Heart Center, Leipzig, Germany
2 Heart Center Hirslanden, Zurich, Switzerland

* Corresponding author. E-mail address: hindg@medizin.uni-leipzig.de

This editorial refers to ‘A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF)’ by C. Blomström-Lundqvist et al., on page 2902

Footnotes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

The first 10% of the full text of this article appears below.

Curative treatment strategies for patients with atrial fibrillation were introduced in the late 1980s by Cox and co-coworkers.1 Following extensive animal experimental studies, the Maze procedure was developed and applied clinically. Subsequently, modifications of the initial surgical strategy were introduced, i.e. the Maze II and Maze III procedure.2,3 The efficacy of the Maze operation to establish permanent and stable sinus rhythm in >90% of patients treated was impressive.4 For a long time, the Maze III was cited as the ‘gold standard’ for the curative treatment of atrial fibrillation, but the extensive and time-consuming nature of this ‘cut and sew’ procedure prevented its widespread use. However, the curative potential of the Maze operation was recognized and inspired interventional electrophysiologists to attempt to reproduce the Maze . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF)
Carina Blomström-Lundqvist, Birgitta Johansson, Eva Berglin, Leif Nilsson, Steen M. Jensen, Stefan Thelin, Anders Holmgren, Nils Edvardsson, Göran Källner, and Per Blomström
EHJ 2007 28: 2902-2908. [Abstract] [FREE Full Text]